Irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) are two chronic gastrointestinal disorders that share ...
Researchers examined the relationship between a diet that provokes inflammation and the risk for irritable bowel syndrome.
Discover a study that investigated how vedolizumab affects the immune cells circulating in the blood, focusing on which ...
A research team has developed a new class of oral peptide therapeutic leads for treating chronic abdominal pain. This groundbreaking innovation offers a safe, non-opioid-based solution for conditions ...
Risk factors for IBS may include HIV infection; however, additional large-scale studies are necessary to draw sound conclusions.
Brooke Abbott Abron faced significant barriers to diagnosis and adequate care for Crohn's disease, rooted in systemic racism ...
University of Queensland researchers have developed a new class of oral painkillers to suppress chronic abdominal pain that ...
Recent research into the role of gluten and wheat in triggering symptoms for people with Irritable Bowel Syndrome (IBS) ...
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel ...
Researchers at the University of Vienna have developed gut-stable oxytocin analogues designed for targeted treatment of ...